dc.contributor.author |
Mekonnen, B. |
|
dc.contributor.author |
Mihret, A. |
|
dc.contributor.author |
Getahun, M. |
|
dc.contributor.author |
Hailu, T. |
|
dc.contributor.author |
Sidiki, S. |
|
dc.contributor.author |
Kelley, H.V. |
|
dc.contributor.author |
Scordo, J.M. |
|
dc.contributor.author |
Hunt, W.G. |
|
dc.contributor.author |
Pan, X. |
|
dc.contributor.author |
Balada-Llasat, J.-M. |
|
dc.contributor.author |
Gebreyes, W. |
|
dc.contributor.author |
Evans, Carlton Anthony William |
|
dc.contributor.author |
Aseffa, A. |
|
dc.contributor.author |
Torrelles, J.B. |
|
dc.contributor.author |
Wang, S.-H. |
|
dc.contributor.author |
Abebe, T. |
|
dc.date.accessioned |
2019-07-04T16:59:34Z |
|
dc.date.available |
2019-07-04T16:59:34Z |
|
dc.date.issued |
2019 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/6792 |
|
dc.description.abstract |
Timely diagnosis of tuberculosis (TB) is limited in Ethiopia. We evaluated the performance of a low technology, thin layer agar, Mycobacterium tuberculosis (M.tb) culture color plate (TB-CX) test with concurrent drug susceptibility testing (DST) to isoniazid (INH), rifampin (RIF), and pyrazinamide (PZA) directly from sputum specimens. Patients undergoing examination for TB and multidrug-resistant (MDR)-TB were enrolled in Addis Ababa, Ethiopia from March 2016 to February 2017. All subjects received a GeneXpert MTB/RIF PCR test. TB-CX test results were compared to reference Löwenstein-Jensen (LJ) culture for M.tb detection and DST for susceptibility to INH and RIF. Kappa statistic was applied to test agreement between results for TB-CX test and the reference methods, a cut-off Kappa value of 0.75 was considered as high level of agreements. A total of 137 participants were analyzed: 88 (64%) were new TB cases, 49 (36%) were re-treatment cases. The TB-CX test detected M.tb and DST in an average of 13 days compared to 50 days for the conventional DST result. The sensitivity and specificity of the TB-CX test for detecting M.tb were 94% and98%, respectively (concordance, 96%; kappa 0.91). The sensitivity of the TB-CX test to detect drug resistance to INH, RIF, and MDR-TB was 91%, 100%, and 90% respectively. The specificity of the TB-CX test for detecting INH, RIF, and MDR-TB was 94%, 40%, and 94% respectively. Overall agreement between TB-CX test and LJ DST for detection of MDR-TB was 93%. The TB-CX test showed strong agreement with the GeneXpert test for detecting M.tb (89%, kappa 0.76) but low agreement for the detection of RIF resistance (57%, kappa 0.28). The TB-CX test was found to be a good alternative method for screening of TB and selective drug resistant-TB in a timely and cost-efficient manner. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Public Library of Science |
|
dc.relation.ispartofseries |
PLoS ONE |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Drug screening |
en_US |
dc.subject |
Tuberculosis |
en_US |
dc.subject |
Mycobacterium tuberculosis |
en_US |
dc.subject |
Sputum |
en_US |
dc.subject |
Extensively drug-resistant tuberculosis |
en_US |
dc.subject |
Multi-drug-resistant tuberculosis |
en_US |
dc.subject |
Tuberculosis diagnosis and management |
en_US |
dc.subject |
Drug therapy |
en_US |
dc.title |
Evaluation of the tuberculosis culture color plate test for rapid detection of drug susceptible and drug-resistant Mycobacterium tuberculosis in a resource-limited setting, Addis Ababa, Ethiopia |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1371/journal.pone.0215679 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.07 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.01.05 |
|
dc.relation.issn |
1932-6203 |
|